CHRONIC SPONTANEOUS URTICARIA
Clinical trials for CHRONIC SPONTANEOUS URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Long-Term control of chronic hives
Disease control TerminatedThis study is testing the long-term safety and effectiveness of a drug called briquilimab for people with chronic hives. It includes 67 participants who have already completed a previous trial with the same drug. The goal is to see if briquilimab remains safe and helps control hi…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill for stubborn hives shows promise, but trial halted early
Symptom relief TerminatedThis Phase 2 trial tested an experimental drug called EP262 in 113 people with chronic spontaneous urticaria (long-lasting hives with no clear cause). Participants took either EP262 or a placebo daily for 6 weeks, while continuing their usual antihistamines. The study aimed to se…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Escient Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New study tracks dupilumab for chronic hives in Real-World settings
Knowledge-focused TerminatedThis study watches 400 people with chronic spontaneous urticaria (long-lasting hives) who are prescribed dupilumab by their doctor. Researchers collect information from medical records and patient surveys to see how the drug works in real life, its safety, and how it affects qual…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC